JBSS vs JNJ · P/E 13, rev $1.18B vs P/E 17, rev $49.37B
John B Sanfilippo & Son Inc (JBSS) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
John B Sanfilippo & Son Inc (JBSS) is a packaged foods company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported JBSS revenue for 2026-06-25 was $1.18B. Net income was $61.9M. Revenue was up 6.2% from 2025-06-26 to 2026-06-25. JBSS currently screens at market cap $868.4M and trailing P/E 13.0.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
JBSS currently screens at market cap $868.4M and trailing P/E 13.0. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the JBSS and JNJ stock pages for the full models.
Not investment advice.